News

Absci Corporation’s ABSI share price has dipped by 5.12%, which has investors questioning if this is right time to buy.
Accurate genomic profiling is essential for clinical decision-making and optimizing treatment recommendations.
Y-mAbs Therapeutics, Inc.’s YMAB share price has dipped by 5.65%, which has investors questioning if this is right time to ...
MONDAY, April 21, 2025 (HealthDay News) — Immunotherapy might help keep lung cancer at bay for months or even years after the treatment has been abandoned due to side effects, a new study says. Immune ...
Discover the winners and highlights from the 2025 GeekWire Awards, honoring top startups, innovators, and tech leaders in ...
A new study points to a bacterial toxin as fueling a rise in early-onset colorectal cancer cases. But what is this toxin—and ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Pennington Biomedical Research Center is pleased to announce the arrival of Dr. Adithya Hari, MD, as Assistant Professor and ...
Electronic nose breath analysis achieved 80-92% accuracy for detecting lung cancer in patients with suspicious findings. Detection accuracy remained consistent across tumor characteristics ...
The American Association for Cancer Research (AACR) will honor the following cancer researchers and physician-scientists during the AACR Annual Meeting 2025, to be held April 25-30 at the McCormick ...
Not There Yet In its current state, eNose (or E-nose) technology "can be considered complementary to the CT scan," said Gaetano Rocco, MD, of Memorial Sloan Kettering (MSK) Cancer Center in New ...
But, explained medical physicist Lawrence Dauer of Memorial Sloan Kettering in New York City ... receives about three mSv per year from natural background radiation, which includes cosmic ...